Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2023-01-13 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for January 27, 2023. The purpose of the meeting is to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2022. It also mentions the closure of the trading window for insiders in compliance with insider trading regulations. The document does not contain any financial data or results itself, nor does it include a report or detailed financial statements. It is an announcement about a board meeting and related compliance matters. Given the content and length (2272 characters), this is not a full financial report or earnings release but a regulatory announcement about a board meeting and upcoming financial results approval. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-01-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter from the company to stock exchanges notifying about an upcoming Board Meeting scheduled to approve the unaudited financial results for the third quarter and nine months ended December 31, 2022. It references regulatory compliance under SEBI Listing Obligations and Insider Trading Regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notification of a board meeting and trading window closure, not the actual financial report or earnings release. The document length is short (2272 characters), and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and announcement documents that do not fit other specific categories.
2023-01-13 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a certified copy of the minutes of resolutions passed by postal ballot through remote e-voting by shareholders of Glenmark Life Sciences Limited. It details the voting results for the appointment of a director and a whole-time director, including vote counts and percentages. The document references the Companies Act, 2013, and SEBI regulations, and it is addressed to stock exchanges. The content is focused on the official results of shareholder voting on specific resolutions, not on the full report or presentation of the meeting itself. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, confirming it is not a mere announcement or a short notice. Therefore, the correct classification is DVA with high confidence.
2023-01-13 English
Shareholders meeting
Regulatory Filings
2023-01-03 English
Newspaper Advertisements
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about a Postal Ballot Notice and e-Voting information, pursuant to SEBI regulations. It includes regulatory compliance information and notices related to corporate governance and shareholder voting procedures. There is no detailed financial data, earnings information, or full report content. The document is primarily an announcement of a notice related to shareholder voting and regulatory compliance, not the report or results themselves. Therefore, it fits best under Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). Since it specifically mentions a Postal Ballot Notice and e-Voting information, which are materials sent to shareholders to provide information and request votes, the classification aligns with Proxy Solicitation & Information Statement (PSI).
2022-12-03 English
Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice regarding a postal ballot for shareholder approval of resolutions related to the appointment of a director and whole-time director. It references the Companies Act, SEBI Listing Regulations, and details the voting process and timeline. The content is focused on informing shareholders about the voting process and the resolutions to be considered, not the results of the vote or the meeting itself. It is not a full report or financial statement but a formal announcement of a voting process. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice for a postal ballot seeking shareholder approval and providing detailed information about the resolutions and voting process, it aligns best with Proxy Solicitation & Information Statement (PSI).
2022-12-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.